Journal
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
Volume 107, Issue 5, Pages 933-943Publisher
WILEY
DOI: 10.1002/jbm.a.36635
Keywords
antithrombogenicity; phosphorylcholine group; surface modification; protein adsorption; cell adhesion
Funding
- Japanese Society for Biomaterials (JSB)
- Japan Science and Technology Agency (JST)
Ask authors/readers for more resources
In the last 40 years, many strategies to fabricate biocompatible and antithrombogenic polymers have been proposed, especially in Japan. The development of one such polymers composed of 2-methacryloyloxyethyl phosphorylcholine unit, is described in this review, with specific examples of use in biomedical devices. These polymers are typically incorporated into other materials to effectively prevent unfavorable biological responses and reactions. For example, the polymers suppress protein adsorption and cell adhesion to materials in contact with plasma or whole blood, even in the absence of anticoagulant. These properties are due to the extreme hydrophilicity and electrically neutral nature of the polymers, as well as to the ability of phosphorylcholine to induce bulk-like behavior in surrounding waters. Accordingly, these polymers have been used worldwide to modify the surfaces and improve the overall biocompatibility of such medical devices as long-term implantable artificial organs. (c) 2019 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 107A: 933-943, 2019.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available